MedPath

Humidified Culture and Live Birth After ICSI

Not Applicable
Completed
Conditions
Infertility
Interventions
Other: Human embryo culture
Registration Number
NCT03823235
Lead Sponsor
Ibn Sina Hospital
Brief Summary

Humidity for human embryo culture has been raised as essential with advantageous effect on clinical pregnancy and ongoing pregnancy after ICSI compared with a dry incubator. Whether the deleterious effect of dry culture would have an extended effect reaches the live birth rate needs to be examined. This RCT is to examine the effect of dry and humidified culture on live birth rates after ICSI.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1837
Inclusion Criteria
  • Women undergoing a first or second ICSI attempts
  • Primary or secondary infertility with a BMI of < 31 kg/m2
  • Duration of infertility of ≥ 18 months and normal baseline ultrasonography
  • 18 to 40 years of age
  • Tubal factor, male factor, polycystic ovary, unexplained infertility or combined factors
  • Tubal factors
Exclusion Criteria
  • Surgically-retrieved, frozen-thawed and pinpoint sperm or globozoospermia
  • Thin endometrium
  • Uterine anomaly and adhesion
  • Adenomyosis
  • Submucous myoma
  • Endometriosis
  • Severe medical condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Culture of human embryo in non-humidified incubatorHuman embryo cultureEmbryo culture after in vitro fertilization in incubator with no humidity
Primary Outcome Measures
NameTimeMethod
Live birth rate30 weeks

Viable neonate after 30 weeks of gestation per initiated cycle

Secondary Outcome Measures
NameTimeMethod
Cumulative ongoing pregnancy rate12 weeks of gestation

Continued pregnancy after 12 weeks of gestation per initiated cycle within one year of randomization

Preterm birth rate37 weeks

number of babies born before 37 weeks of gestation per total birth

Cleavage rate6 days of culture

Cleaved embryo per fertilized oocyte

Blastocyst formation rate6 days of culture

Formed blastocyst on day 5/6 from fertilized oocytes

Rate of high-quality blastocyst6 days of culture

Blastocysts ≥ 3.1.1 grade per fertilized oocyte

Ongoing pregnancy rate12 weeks of gestation

Continued pregnancy after 12 weeks of gestation per initiated cycle

Implantation rate7 weeks of gestation

Number of sacs with a heartbeat per number of embryo transferred

Ongoing implantation rate12 weeks of gestation

Number of sacs with a heartbeat per number of embryo transferred

Fertilization rate6 days of culture

fertilized oocytes with two pronuclei per Metaphase II injected

Rate of high-quality day-3 embryos6 days of culture

Embryos with seven or eight blastomeres of appropriate-size, and \< 10% fragmentation by volume per fertilized oocyte

Rate of utilizable blastocyst6 days of culture

Transferred and cryopreserved blastocysts from fertilized oocytes

Cumulative clinical pregnancy rate7 weeks of gestation

Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle within one year of randomization

Very preterm birth32 weeks

number of babies born before 32 weeks of gestation per total birth

Low birth weight rate40 weeks of gestation

number of babies with \< 2500 gm per total birth

Cumulative live birth rateOne year

Viable neonate after 30 weeks of gestation after one fresh and/or one frozen-warmed transfer per initiated cycle

Clinical pregnancy rate7 weeks of gestation

Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle

Cumulative implantation rate7 weeks of gestation

Number of sacs with a heartbeat per number of embryo transferred within one year of randomization

Cumulative ongoing implantation rate12 weeks of gestation

Number of sacs with a heartbeat per number of embryo transferred within one year of randomization

Trial Locations

Locations (3)

Qena Fertility Center

🇪🇬

Qena, Egypt

IbnSina IVF Center

🇪🇬

Sohag, Egypt

Banon Assiut

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath